Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-01-20

FDA Approved: PAROXETINE — Original Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin Pharmaceuticals' original application for Paroxetine, a generic selective serotonin reuptake inhibitor. The approval expands access to paroxe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Paroxetine (Paroxetine hydrochloride)

Snippet

ORIG AP for PAROXETINE (PAROXETINE)